Search

Your search keyword '"Iwata, Takehiro"' showing total 197 results
Start Over Author "Iwata, Takehiro"
197 results on '"Iwata, Takehiro"'

2. Differential effect of surgical technique on intravesical recurrence after radical nephroureterectomy in patients with upper tract urothelial cancer: a systematic review and Meta-analysis

Author

Tsuboi, Ichiro, Matsukawa, Akihiro, Kardoust Parizi, Mehdi, Klemm, Jakob, Schulz, Robert J, Cadenar, Anna, Mancon, Stefano, Chiujdea, Sever, Fazekas, Tamás, Miszczyk, Marcin, Laukhtina, Ekaterina, Kawada, Tatsushi, Katayama, Satoshi, Iwata, Takehiro, Bekku, Kensuke, Wada, Koichiro, Gontero, Paolo, Rouprêt, Morgan, Teoh, Jeremy, Singla, Nirmish, Araki, Motoo, and Shariat, Shahrokh F.

Published
2024
Full Text
View/download PDF

4. Effect of Antacids on the Survival of Patients With Metastatic Urothelial Carcinoma Treated With Pembrolizumab

Author

Sekito, Takanori, Bekku, Kensuke, Katayama, Satoshi, Watanabe, Tomofumi, Tsuboi, Ichiro, Yoshinaga, Kasumi, Maruyama, Yuki, Yamanoi, Tomoaki, Kawada, Tatsushi, Tominaga, Yusuke, Sadahira, Takuya, Iwata, Takehiro, Nishimura, Shingo, Kusumi, Norihiro, Edamura, Kohei, Kobayashi, Tomoko, Kurose, Kyohei, Ichikawa, Takaharu, Miyaji, Yoshiyuki, Wada, Koichiro, Kobayashi, Yasuyuki, and Araki, Motoo

Published
2024
Full Text
View/download PDF

5. The Impact of Concomitant Medications on the Overall Survival of Patients Treated with Systemic Therapy for Advanced or Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-analysis

Author

Tsuboi, Ichiro, Matsukawa, Akihiro, Parizi, Mehdi Kardoust, Miszczyk, Marcin, Fazekas, Tamás, Schulz, Robert J., Mancon, Stefano, Litterio, Giulio, Laukhtina, Ekaterina, Kawada, Tatsushi, Katayama, Satoshi, Iwata, Takehiro, Bekku, Kensuke, Rajwa, Pawel, Wada, Koichiro, Karakiewicz, Pierre I., Araki, Motoo, and Shariat, Shahrokh F.

Published
2024
Full Text
View/download PDF

6. Oncological Outcomes of Active Surveillance versus Surgery or Ablation for Patients with Small Renal Masses: A Systematic Review and Quantitative Analysis

Author

Tsuboi, Ichiro, Rajwa, Pawel, Campi, Riccardo, Miszczyk, Marcin, Fazekas, Tamás, Matsukawa, Akihiro, Kardoust Parizi, Mehdi, Schulz, Robert J., Mancon, Stefano, Cadenar, Anna, Laukhtina, Ekaterina, Kawada, Tatsushi, Katayama, Satoshi, Iwata, Takehiro, Bekku, Kensuke, Wada, Koichiro, Karakiewicz, Pierre I., Remzi, Mesut, Araki, Motoo, and Shariat, Shahrokh F.

Published
2024
Full Text
View/download PDF

7. Prognostic impact of radiological tumor burden in patients with metastatic urothelial carcinoma treated with pembrolizumab

Author

Katayama, Satoshi, Iwata, Takehiro, Kawada, Tasushi, Okamoto, Yusuke, Sano, Yuho, Kawago, Yuya, Miyake, Shuji, Moriwake, Takatoshi, Kuinose, Aya, Horikawa, Yuhei, Tsuboi, Kazuma, Tsuboi, Ichiro, Sakaeda, Kazuma, Nakatsuka, Hirokazu, Takamoto, Atsushi, Hirata, Takeshi, Shirasaki, Yoshinori, Yamasaki, Taku, Morinaka, Hirofumi, Nagasaki, Naoya, Hara, Takafumi, Ochi, Akinori, Okumura, Misa, Watanabe, Tomofumi, Sekito, Takanori, Kawano, Kaoru, Horii, Satoshi, Yamanoi, Tomoaki, Nagao, Kentaro, Yoshinaga, Kasumi, Maruyama, Yuki, Tominaga, Yusuke, Sadahira, Takuya, Nishimura, Shingo, Edamura, Kohei, Kobayashi, Tomoko, Kusumi, Norihiro, Kurose, Kyohei, Yamamoto, Yasuo, Sugimoto, Morito, Nakada, Tetsuya, Sasaki, Katsumi, Takenaka, Tadasu, Ebara, Shin, Miyaji, Yoshiyuki, Wada, Koichiro, Kobayashi, Yasuyuki, and Araki, Motoo

Published
2024
Full Text
View/download PDF

9. Trans men can achieve adequate muscular development through low‐dose testosterone therapy: A long‐term study on body composition changes

Author

Tominaga, Yusuke, primary, Kobayashi, Tomoko, additional, Matsumoto, Yuko, additional, Moriwake, Takatoshi, additional, Oshima, Yoshitaka, additional, Okumura, Misa, additional, Horii, Satoshi, additional, Sadahira, Takuya, additional, Katayama, Satoshi, additional, Iwata, Takehiro, additional, Nishimura, Shingo, additional, Bekku, Kensuke, additional, Edamura, Kohei, additional, Sugimoto, Morito, additional, Kobayashi, Yasuyuki, additional, Watanabe, Masami, additional, Namba, Yuzaburo, additional, Matsumoto, Yosuke, additional, Nakatsuka, Mikiya, additional, and Araki, Motoo, additional

Published
2024
Full Text
View/download PDF

11. Current status and future perspectives on robot‐assisted kidney autotransplantation: A literature review.

Author

Sekito, Takanori, Yamanoi, Tomoaki, Sadahira, Takuya, Yoshinaga, Kasumi, Maruyama, Yuki, Tominaga, Yusuke, Katayama, Satoshi, Iwata, Takehiro, Nishimura, Shingo, Bekku, Kensuke, Edamura, Kohei, Kobayashi, Tomoko, Kobayashi, Yasuyuki, and Araki, Motoo

Subjects
MINIMALLY invasive procedures, LITERATURE reviews, UROLOGICAL surgery, NEPHRECTOMY, AUTOTRANSPLANTATION, SURGICAL robots, KIDNEY transplantation
Abstract

This review presents the latest insights on robot‐assisted kidney autotransplantation (RAKAT). RAKAT is a minimally invasive surgical procedure and represents a promising alternative to conventional laparoscopic nephrectomy followed by open kidney transplantation for the treatment of various complex urological and vascular conditions. RAKAT can be performed either extracorporeally or intracorporeally. Additionally, a single‐port approach can be performed through one small incision without the need to reposition the patient. Of 86 patients undergoing RAKAT, 8 (9.3%) developed postoperative > Grade 2 Clavien‐Dindo (CD) complications. Although the feasibility of RAKAT was established in 2014, the long‐term efficacy and safety along with outcomes of this surgical approach are still being evaluated, and additional studies are needed. With improvements in the technology of RAKAT and as surgeons gain more experience, RAKAT should become increasingly used and further refined, thereby leading to improved surgical outcomes and improved patients' quality of life. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

13. Prognostic impact of radiological tumor burden in patients with metastatic urothelial carcinoma treated with pembrolizumab

Author

Katayama, Satoshi, primary, Iwata, Takehiro, additional, Kawada, Tasushi, additional, Okamoto, Yusuke, additional, Sano, Yuho, additional, Kawago, Yuya, additional, Miyake, Shuji, additional, Moriwake, Takatoshi, additional, Kuinose, Aya, additional, Horikawa, Yuhei, additional, Tsuboi, Kazuma, additional, Tsuboi, Ichiro, additional, Sakaeda, Kazuma, additional, Nakatsuka, Hirokazu, additional, Takamoto, Atsushi, additional, Hirata, Takeshi, additional, Shirasaki, Yoshinori, additional, Yamasaki, Taku, additional, Morinaka, Hirofumi, additional, Nagasaki, Naoya, additional, Hara, Takafumi, additional, Ochi, Akinori, additional, Okumura, Misa, additional, Watanabe, Tomofumi, additional, Sekito, Takanori, additional, Kawano, Kaoru, additional, Horii, Satoshi, additional, Yamanoi, Tomoaki, additional, Nagao, Kentaro, additional, Yoshinaga, Kasumi, additional, Maruyama, Yuki, additional, Tominaga, Yusuke, additional, Sadahira, Takuya, additional, Nishimura, Shingo, additional, Edamura, Kohei, additional, Kobayashi, Tomoko, additional, Kusumi, Norihiro, additional, Kurose, Kyohei, additional, Yamamoto, Yasuo, additional, Sugimoto, Morito, additional, Nakada, Tetsuya, additional, Sasaki, Katsumi, additional, Takenaka, Tadasu, additional, Ebara, Shin, additional, Miyaji, Yoshiyuki, additional, Wada, Koichiro, additional, Kobayashi, Yasuyuki, additional, and Araki, Motoo, additional

Published
2023
Full Text
View/download PDF

14. Photodynamic diagnostic ureteroscopy using the VISERA ELITE video system for diagnosis of upper-urinary tract urothelial carcinoma: a prospective cohort pilot study

Author

Wada, Koichiro, Araki, Motoo, Tanimoto, Ryuta, Sadahira, Takuya, Watari, Shogo, Maruyama, Yuki, Mitsui, Yosuke, Nakajima, Hirochika, Acosta, Herik, Katayama, Satoshi, Iwata, Takehiro, Nishimura, Shingo, Takamoto, Atsushi, Sako, Tomoko, Edamura, Kohei, Kobayashi, Yasuyuki, Watanabe, Masami, Watanabe, Toyohiko, and Nasu, Yasutomo

Published
2021
Full Text
View/download PDF

22. The Diagnosis and Treatment Approach for Oligo-Recurrent and Oligo-Progressive Renal Cell Carcinoma.

Author

Bekku, Kensuke, Kawada, Tatsushi, Sekito, Takanori, Yoshinaga, Kasumi, Maruyama, Yuki, Yamanoi, Tomoaki, Tominaga, Yusuke, Sadahira, Takuya, Katayama, Satoshi, Iwata, Takehiro, Nishimura, Shingo, Edamura, Kohei, Kobayashi, Tomoko, Kobayashi, Yasuyuki, Araki, Motoo, and Niibe, Yuzuru

Subjects
RENAL cell carcinoma, DISEASE progression, IMMUNE checkpoint inhibitors, METASTASIS, CANCER relapse, METASTASECTOMY
Abstract

Simple Summary: Oligo-recurrence and oligo-progression in oncology refer to scenarios in which five or fewer metastases develop after the primary lesions and other metastases have been treated using radical surgery or controlled using systemic therapy. Such scenarios are now considered favorable indications for metastasis-directed treatment (MDT), where a curative approach is possible. The primary strategy for recurrence and metastases in renal cell carcinoma (RCC) is systemic therapy, which includes immune checkpoint inhibitors (ICIs) and vascular endothelial growth factor receptor tyrosine kinase inhibitors. However, MDTs such as stereotactic body radiation therapy, which involves larger doses administered over fewer fractions than conventional radiation therapy, have shown the potential to improve outcomes for selected patients with RCC experiencing oligo-recurrence and oligo-progression. Combining MDT with ICIs may yield better results owing to their synergistic effects. In this review, we provide an overview of the current evidence related to the management of oligo-recurrent and -progressive RCC. One-third of renal cell carcinomas (RCCs) without metastases develop metastatic disease after extirpative surgery for the primary tumors. The majority of metastatic RCC cases, along with treated primary lesions, involve limited lesions termed "oligo-recurrent" disease. The role of metastasis-directed therapy (MDT), including stereotactic body radiation therapy (SBRT) and metastasectomy, in the treatment of oligo-recurrent RCC has evolved. Although the surgical resection of all lesions alone can have a curative intent, SBRT is a valuable treatment option, especially for patients concurrently receiving systemic therapy. Contemporary immune checkpoint inhibitor (ICI) combination therapies remain central to the management of metastatic RCC. However, one objective of MDT is to delay the initiation of systemic therapies, thereby sparing patients from potentially unnecessary burdens. Undertaking MDT for cases showing progression under systemic therapies, known as "oligo-progression", can be complex in considering the treatment approach. Its efficacy may be diminished compared to patients with stable disease. SBRT combined with ICI can be a promising treatment for these cases because radiation therapy has been shown to affect the tumor microenvironment and areas beyond the irradiated sites. This may enhance the efficacy of ICIs, although their efficacy has only been demonstrated in clinical trials. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

25. MP31-17 LOW-DOSE RITUXIMAB INDUCTION THERAPY IN IMMUNOLOGIC HIGH-RISK RENAL TRANSPLANTATION PROVIDES FAVORABLE GRAFT OUTCOMES WITHOUT INCREASING CYTOMEGALOVIRUS INFECTION: A 5-YEAR FOLLOW-UP

Author

Yoshinaga, Kasumi, primary, Maruyama, Yuki, additional, Yamanoi, Tomoaki, additional, Nishimura, Shingo, additional, Tominaga, Yusuke, additional, Katayama, Satoshi, additional, Iwata, Takehiro, additional, Edamura, Kohei, additional, Kobayashi, Tomoko, additional, Kobayashi, Yasuyuki, additional, Watanabe, Toyohiko, additional, and Araki, Motoo, additional

Published
2023
Full Text
View/download PDF

27. The Genotypic and Phenotypic Characteristics Contributing to Flomoxef Sensitivity in Clinical Isolates of ESBL-Producing E. coli Strains from Urinary Tract Infections

Author

Sakaeda, Kazuma, Sadahira, Takuya, Maruyama, Yuki, Iwata, Takehiro, Watanabe, Masami, Wada, Koichiro, Araki, Motoo, Sakaeda, Kazuma, Sadahira, Takuya, Maruyama, Yuki, Iwata, Takehiro, Watanabe, Masami, Wada, Koichiro, and Araki, Motoo

Abstract

We carried out a molecular biological analysis of extended-spectrum beta-lactamase (ESBL)-producing E. coli strains and their sensitivity to flomoxef (FMOX). Sequence type (ST) analysis by multilocus sequence typing (MLST) and classification of ESBL genotypes by multiplex PCR were performed on ESBL-producing E. coli strains isolated from urine samples collected from patients treated at our institution between 2008 and 2018. These sequences were compared with results for antimicrobial drug susceptibility determined using a micro-liquid dilution method. We also analyzed cases treated with FMOX at our institution to examine its clinical efficacy. Of the 911 E. coli strains identified, 158 (17.3%) were ESBL-producing. Of these, 67.7% (107/158) were strain ST-131 in ST analysis. Nearly all (154/158; 97.5%) were CTX-M genotypes, with M-14 and M-27 predominating. The isolated strains were sensitive to FMOX in drug susceptibility tests. Among the patient samples, 33 cases received FMOX, and of these, 5 had ESBL-producing E. coli. Among these five cases, three received FMOX for surgical prophylaxis as urinary carriers of ESBL-producing E. coli, and postoperative infections were prevented in all three patients. The other two patients received FMOX treatment for urinary tract infections. FMOX treatment was successful for one, and the other was switched to carbapenem. Our results suggest that FMOX has efficacy for perioperative prophylactic administration in urologic surgery involving carriers of ESBL-producing bacteria and for therapeutic administration for urinary tract infections. Use of FMOX avoids over-reliance on carbapenems or beta-lactamase inhibitors and thus is an effective antimicrobial countermeasure.

Published
2023

28. Etiology of recurrent cystitis in postmenopausal women based on vaginal microbiota and the role of Lactobacillus vaginal suppository

Author

Sekito, Takanori, Wada, Koichiro, Ishii, Ayano, Iwata, Takehiro, Matsubara, Takehiro, Tomida, Shuta, Watanabe, Masami, Araki, Motoo, Sadahira, Takuya, Sekito, Takanori, Wada, Koichiro, Ishii, Ayano, Iwata, Takehiro, Matsubara, Takehiro, Tomida, Shuta, Watanabe, Masami, Araki, Motoo, and Sadahira, Takuya

Abstract

Background: The vaginal microbiota can be altered by uropathogenic bacteria associated with recurrent cystitis (RC), and the vaginal administration of Lactobacillus have suggested certain effects to prevent RC. The relationship between vaginal microbiota and the development of RC has not been elucidated. We aimed to clarify the etiology of RC from vaginal microbiota and importance of vaginal Lactobacillus. Methods: Vaginal samples obtained from 39 postmenopausal women were classified into four groups: healthy controls; uncomplicated cystitis; RC; and prevention (prevented RC by Lactobacillus crispatus-containing vaginal suppositories). Principal coordinate analysis and beta-diversity analysis was used to assess 16S rRNA gene sequencing data from the vaginal microbiome. Results: Cluster analysis divided the vaginal bacterial communities among 129 vaginal samples into three clusters (A, B, and C). Fourteen of 14 (100%) samples from the RC group and 51 of 53 (96%) samples from the prevention group were in clusters B and C, while 29 of 38 (76%) samples from the healthy group and 14 of 24 (58%) samples from the uncomplicated cystitis group were in cluster A. The principal coordinate analysis showed that plots in the uncomplicated cystitis group were similar to the healthy group, indicating a large separation between the RC group and the uncomplicated cystitis group. On beta-diversity analysis, there were significant differences between the healthy group and the uncomplicated cystitis group (p = 0.045), and between the RC group and the uncomplicated cystitis group or the healthy group (p = 0.001, p = 0.001, respectively). There were no significant differences between the RC group and the prevention group (p = 0.446). The top six taxa were as follows: Prevotella, Lactobacillus, Streptococcus, Enterobacteriaceae, Anaerococcus, and Bifidobacterium. Among patients with RC, Lactobacillus was undetectable before administration of suppositories, while the median relati

Published
2023

30. Bladder tuberculosis with ureteral strictures after bacillus Calmette‑Guérin therapy for urinary bladder cancer: A case report

Author

Tominaga, Yusuke, primary, Fujii, Masanori, additional, Sadahira, Takuya, additional, Katayama, Satoshi, additional, Iwata, Takehiro, additional, Nishimura, Shingo, additional, Bekku, Kensuke, additional, Edamura, Kohei, additional, Kobayashi, Tomoko, additional, Kobayashi, Yasuyuki, additional, Kiura, Katsuyuki, additional, Maeda, Yoshinobu, additional, Wada, Koichiro, additional, and Araki, Motoo, additional

Published
2022
Full Text
View/download PDF

32. Bladder tuberculosis with ureteral strictures after bacillus Calmette‑Guérin therapy for urinary bladder cancer: A case report

Author

Tominaga, Yusuke, Fujii, Masanori, Sadahira, Takuya, Katayama, Satoshi, Iwata, Takehiro, Nishimura, Shingo, Bekku, Kensuke, Edamura, Kohei, Kobayashi, Tomoko, Kobayashi, Yasuyuki, Kiura, Katsuyuki, Maeda, Yoshinobu, Wada, Koichiro, Araki, Motoo, Tominaga, Yusuke, Fujii, Masanori, Sadahira, Takuya, Katayama, Satoshi, Iwata, Takehiro, Nishimura, Shingo, Bekku, Kensuke, Edamura, Kohei, Kobayashi, Tomoko, Kobayashi, Yasuyuki, Kiura, Katsuyuki, Maeda, Yoshinobu, Wada, Koichiro, and Araki, Motoo

Abstract

Intravesical immunotherapy using bacillus Calmette‑Guérin (BCG) is recommended for patients with intermediate‑ to high‑risk non‑muscle invasive bladder cancer. Bladder tuberculosis (TB) is a rare complication of BCG therapy. The present study describes the case of a 73‑year‑old man who underwent intravesical BCG therapy for urothelial carcinoma in situ of the bladder. Red patches around the resection scar were first detected 1 year and 5 months after BCG treatment; these findings gradually spread to encompass more of the bladder wall. Transurethral biopsy revealed a benign lesion, but the patient developed bilateral hydronephrosis and mild voiding dysfunction. The patient was eventually diagnosed with bladder TB by mycobacterial urine culture and TB‑specific polymerase chain reaction (PCR). The patient was given multidrug therapy (isoniazid, rifampicin and ethambutol) and their bladder TB was completely cured; however, their voiding dysfunction and bilateral hydronephrosis did not fully improve. Bladder TB can occur long after intravesical BCG administration and cystoscopy findings consistent with inflammation can be the key to suspecting this condition. Acid‑fast examination and PCR testing of a urine sample are necessary for early diagnosis.

Published
2022

33. Efficacy and safety of 3 day versus 7 day cefditoren pivoxil regimens for acute uncomplicated cystitis: multicentre, randomized, open-label trial

Author

Sadahira, Takuya, Wada, Koichiro, Araki, Motoo, Ishii, Ayano, Takamoto, Atsushi, Kobayashi, Yasuyuki, Watanabe, Masami, Watanabe, Toyohiko, Nasu, Yasutomo, Kumon, Hiromi, Nasu, Yasutomo, Akaeda, Teruaki, Akazawa, Nobuyuki, Akebi, Naoki, Araki, Daiji, Araki, Tohru, Araki, Motoo, Arata, Ryoji, Ariyoshi, Yuichi, Ando, Eiichi, Ando, Nobuyoshi, Ishii, Ayano, Ishii, Kazushi, Ishikawa, Tsutomu, Ishito, Noritaka, Ichikawa, Takaharu, Inoue, Takaaki, Inoue, Miyabi, Inoue, Yosuke, Irie, Shin, Iwata, Takehiro, Uesugi, Tatsuya, Uehara, Shinya, Uematsu, Katsutoshi, Uno, Satoshi, Edamura, Kohei, Ebara, Shin, Oiwa, Yuko, Oeda, Tadashi, Ohashi, Teruhisa, Ohashi, Yozo, Ozawa, Hideo, Ochi, Junzo, Ono, Noriaki, Kai, Seiji, Kaku, Haruki, Katayama, Satoshi, Katayama, Yasuhiro, Kaneshige, Tetuzo, Kawauchi, Keiichiro, Kawaguchi, Masashi, Kawada, Tatsushi, Kanbara, Taiki, Kishi, Mikio, Kishimoto, Ryo, Kusaka, Nobuyuki, Kusumi, Norihiro, Kunitomi, Kimito, Kubota, Risa, Kumon, Hiromi, Kurahashi, Hiroaki, Kojima, Hironori, Kobayashi, Tomoko, Kobayashi, Yasuyuki, Kobuke, Makoto, Kondo, Katsuyoshi, Saika, Takashi, Sakaeda, Kazuma, Sakuramoto, Koji, Sako, Shinichi, Sako, Tomoko, Sasaoka, Taketo, Sasaki, Katsumi, Sadahira, Takuya, Jo, Yoshimasa, Sugimoto, Morito, Seno, Yuko, Takao, Akira, Takamura, Kosuke, Takamura, Kousuke, Takamoto, Atsushi, Takamoto, Hitoshi, Takeda, Katsuji, Takenaka, Tadasu, Tanaka, Daisuke, Tanimoto, Ryuta, Tsugawa, Masaya, Tsushima, Tomoyasu, Tsuboi, Hiromu, Tojo, Syunji, Tokinaga, Kenji, Tominaga, Yusuke, Doi, Keisuke, Nagai, Atsushi, Nakajima, Hirochika, Nakada, Tetsuya, Nakatsuka, Hirokazu, Nakamura, Aya, Nakayama, Yasuki, Nasu, Yoshitsugu, Nishikawa, Daisuke, Nishiguchi, Jun, Nishitani, Yoshio, Nishimura, Shingo, Nishimura, Motoichi, Nishiyama, Yasuhiro, Nibuno, Hajime, Nozaki, Kunihiro, Nose, Hiroyuki, Noda, Gaku, Hashimoto, Hideaki, Hata, Kazuhiro, Hayashi, Toshihide, Hayashi, Nobuki, Hayata, Syunji, Hara, Ryoei, Hirata, Takeshi, Fujii, Tomohiro, Fujio, Kei, Fujita, Ryuji, Bekku, Kensuke, Maehara, Takanori, Maki, Yoshio, Matsumoto, Yuko, Manabe, Daisuke, Mayumi, Yusuke, Maruyama, Yuki, Mitsui, Yosuke, Miyaji, Sadayuki, Munemasa, Syuhei, Murao, Wataru, Murakami, Takanori, Murata, Tadashi, Mori, Akihiro, Morita, Akira, Monden, Koichi, Yamasaki, Tomoya, Yamashita, Masahiro, Yamada, Daiduke, Yamato, Toyoko, Yamane, Toru, Yamanoi, Tomoaki, Yamamoto, Yasuo, Yukari, Kazuaki, Yokoyama, Teruhiko, Yoshioka, Takashi, Watanabe, Toyohiko, Watanabe, Masami, Watanabe, Yuichi, and Wada, Koichiro

Published
2017
Full Text
View/download PDF

34. A Novel Technique Using Fluorescent Ureteral Catheter and Flexible Ureteroscope for Safe Laparoscopic Fenestration of Lymphocele after Kidney Transplantation

Author

Sekito, Takanori, Araki, Motoo, Wada, Koichiro, Yoshinaga, Kasumi, Maruyama, Yuki, Sadahira, Takuya, Katayama, Satoshi, Iwata, Takehiro, Nishimura, Shingo, Sako, Tomoko, Edamura, Kohei, Kobayashi, Yasuyuki, and Watanabe, Toyohiko

Subjects
surgical procedures, operative, Article Subject, urologic and male genital diseases
Abstract

Laparoscopic fenestration of a postrenal transplant lymphocele is associated with a risk of renal hilar vessel and ureteral injury. Consequently, determination of the incision line is difficult. We describe a case of a 73-year-old man with postrenal transplant lymphocele who underwent a laparoscopic fenestration. We report a surgical video containing a new technique of laparoscopic fenestration using a fluorescent ureteral catheter in combination with a flexible ureteroscope. The combination of a fluorescent ureteral catheter and flexible ureteroscope during surgery enabled us to determine the incision line safely and accurately. Intraoperative real-time visualization of the lymphocele and ureter using a fluorescent ureteral catheter and a flexible ureteroscope is safer than conventional methods for laparoscopic fenestration. To the best of our knowledge, this is the first report of this novel technique.

Published
2022
Full Text
View/download PDF

35. Clinical Efficacy and Safety of Sitafloxacin 200 mg Once Daily for Refractory Genitourinary Tract Infections

Author

Iwata, Takehiro, Sadahira, Takuya, Maruyama, Yuki, Sekito, Takanori, Yoshinaga, Kasumi, Watari, Shogo, Nagao, Kentaro, Kawada, Tatsushi, Tominaga, Yusuke, Nishimura, Shingo, Takamoto, Atsushi, Sako, Tomoko, Edamura, Kohei, Kobayashi, Yasuyuki, Araki, Motoo, Ishii, Ayano, Watanabe, Masami, Watanabe, Toyohiko, Nasu, Yasutomo, and Wada, Koichiro

Subjects
Adult, fluoroquinolone resistance, Treatment Outcome, Urinary Tract Infections, extended-spectrum beta-lactamase, Humans, Bacterial Infections, genitourinary tract infections, Anti-Bacterial Agents, Fluoroquinolones
Abstract

The aim of this ongoing trial is to evaluate the clinical efficacy and safety of sitafloxacin (STFX) 200 mg once daily (QD) for 7 days in patients with refractory genitourinary tract infections, which include recurrent or complicated cystitis, complicated pyelonephritis, bacterial prostatitis, and epididymitis. The primary endpoint is the microbiological efficacy at 5-9 days after the last administration of STFX. Recruitment began in February 2021, and the target total sample size is 92 participants.

Published
2021

37. Medical uses for silver nitrate in the urinary tract (Review)

Author

Sekito, Takanori, primary, Sadahira, Takuya, additional, Watanabe, Toyohiko, additional, Maruyama, Yuki, additional, Watanabe, Tomofumi, additional, Iwata, Takehiro, additional, Wada, Koichiro, additional, Edamura, Kohei, additional, Araki, Motoo, additional, and Watanabe, Masami, additional

Published
2022
Full Text
View/download PDF

38. A Case of Metastatic Fumarate Hydratase-Deficient-like Renal Cell Carcinoma Successfully Managed by Ipilimumab plus Nivolumab

Author

Sekito, Takanori, Takamoto, Atsushi, Kobayashi, Yasuyuki, Mitsui, Masao, Watari, Shogo, Kubota, Risa, Sadahira, Takuya, Iwata, Takehiro, Nishimura, Shingo, Edamura, Kohei, Sako, Tomoko, Araki, Motoo, Watanabe, Masami, Watanabe, Toyohiko, Shibata, Rei, Ennishi, Daisuke, and Nasu, Yasutomo

Subjects
Male, renal cell carcinoma, Middle Aged, urologic and male genital diseases, Ipilimumab, Nephrectomy, female genital diseases and pregnancy complications, Kidney Neoplasms, Fumarate Hydratase, Antineoplastic Agents, Immunological, Nivolumab, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, Humans, fumarate hydratase-deficient renal cell carcinoma, Tomography, X-Ray Computed, neoplasms, Carcinoma, Renal Cell, Germ-Line Mutation
Abstract

We report a 62-year-old male with metastatic fumarate hydratase-deficient renal cell carcinoma (FH-deficient RCC) without fumarate hydratase (FH) mutation (FH-deficient–like RCC). The International Metastatic RCC Database Consortium risk score was intermediate, and immunotherapy with nivolumab and ipilimumab (Ipi/ Nivo) was initiated. Four cycles of Ipi/Nivo and 5 cycles of nivolumab resulted in a complete response of the metastases. Hypophysitis occurred as an immune-related adverse event after four cycles of Ipi/Nivo. The prognosis of patients with FH-deficient RCC is generally poor. Few reports of FH-deficient RCC successfully treated with Ipi/Nivo have been published. Ipi/Nivo can be effective for treating FH-deficient RCC.

Published
2021

39. Treatment and Outcome of Metastatic Renal Cell Carcinoma With Sarcomatoid Differentiation: A Single-Center, Real-World Analysis of Retrospective Data

Author

Janisch, Florian, primary, Kienapfel, Christina, additional, Fühner, Constantin, additional, Klotzbücher, Thomas, additional, Marks, Phillip, additional, Hillemacher, Tobias, additional, Meyer, Christian P., additional, Iwata, Takehiro, additional, Parizi, Mehdi Kardoust, additional, Sauter, Guido, additional, Fisch, Margit, additional, Shariat, Shahrokh F., additional, Dahlem, Roland, additional, and Rink, Michael, additional

Published
2021
Full Text
View/download PDF

41. Efficacy of Lactobacillus vaginal suppositories for the prevention of recurrent cystitis: A phase II clinical trial

Author

Sadahira, Takuya, primary, Wada, Koichiro, additional, Araki, Motoo, additional, Mitsuhata, Ritsuko, additional, Yamamoto, Masumi, additional, Maruyama, Yuki, additional, Iwata, Takehiro, additional, Watanabe, Masami, additional, Watanabe, Toyohiko, additional, Kariyama, Reiko, additional, Nasu, Yasutomo, additional, and Ishii, Ayano, additional

Published
2021
Full Text
View/download PDF

42. Impact of paclitaxel, cisplatin, and gemcitabine as first-line chemotherapy in cisplatin-fit and -unfit patients with advanced/metastatic urothelial carcinoma

Author

Katayama, Satoshi, primary, Kobayashi, Yasuyuki, additional, Takamoto, Atsushi, additional, Edamura, Kohei, additional, Sadahira, Takuya, additional, Iwata, Takehiro, additional, Nishimura, Shingo, additional, Sako, Tomoko, additional, Wada, Koichiro, additional, Araki, Motoo, additional, Watanabe, Masami, additional, Watanabe, Toyohiko, additional, and Nasu, Yasutomo, additional

Published
2021
Full Text
View/download PDF

43. Photodynamic Diagnostic Ureteroscopy Using The VISERA ELITE® Video System For Diagnosis of Upper-Urinary Tract Urothelial Carcinoma: A Prospective Cohort Pilot Study

Author

Wada, Koichiro, primary, Araki, Motoo, additional, Tanimoto, Ryuta, additional, Sadahira, Takuya, additional, Watari, Shogo, additional, Maruyama, Yuki, additional, Mitsui, Yosuke, additional, Nakajima, Hirochika, additional, Acosta, Herik, additional, Katayama, Satoshi, additional, Iwata, Takehiro, additional, Nishimura, Shingo, additional, Takamoto, Atsushi, additional, Sako, Tomoko, additional, Edamura, Kohei, additional, Kobayashi, Yasuyuki, additional, Watanabe, Masami, additional, Watanabe, Toyohiko, additional, and Nasu, Yasutomo, additional

Published
2021
Full Text
View/download PDF

45. Differential Impact of Gonadotropin-releasing Hormone Antagonist Versus Agonist on Clinical Safety and Oncologic Outcomes on Patients with Metastatic Prostate Cancer: A Meta-analysis of Randomized Controlled Trials

Author

Abufaraj, Mohammad, primary, Iwata, Takehiro, additional, Kimura, Shoji, additional, Haddad, Anoud, additional, Al-Ani, Hashim, additional, Abusubaih, Lana, additional, Moschini, Marco, additional, Briganti, Alberto, additional, Karakiewicz, Pierre I., additional, and Shariat, Shahrokh F., additional

Published
2021
Full Text
View/download PDF

46. Efficacy of Preoperative Chemotherapy for High Risk Upper Tract Urothelial Carcinoma

Author

Foerster, Beat, primary, Abufaraj, Mohammad, additional, Petros, Firas, additional, Azizi, Mounsif, additional, Gupta, Mohit, additional, Schweitzer, Donald, additional, Margulis, Vitaly, additional, Iwata, Takehiro, additional, Kimura, Shoji, additional, Shabsigh, Ahmad, additional, Briganti, Alberto, additional, Ku, Ja H., additional, Muilwijk, Tim, additional, Kassouf, Wassim, additional, Matin, Surena F., additional, Spiess, Philippe E., additional, Pierorazio, Phillip M., additional, Hendricksen, Kees, additional, Shariat, Shahrokh F., additional, Clinton, Timothy, additional, Broutian, Tatevik, additional, Bandini, Marco, additional, Monteiro, Leonardo L., additional, Liao, Ross, additional, Moschini, Marco, additional, Bivalacqua, Trinity J., additional, Krabbe, Laura-Maria, additional, Nasu, Yasutomo, additional, Egawa, Shin, additional, Joniau, Steven, additional, John, Hubert, additional, van der Heijden, Michiel S., additional, Glybochko, Petr V., additional, Fajkovic, Harun, additional, Singla, Nirmish, additional, and Necchi, Andrea, additional

Published
2020
Full Text
View/download PDF

49. The prognostic value of the urokinase-plasminogen activator system (uPA) in bladder cancer patients treated with radical cystectomy (RC)

Author

Janisch, Florian, primary, D'Andrea, David, additional, Iwata, Takehiro, additional, Kimura, Shoji, additional, Abufaraj, Mohammad, additional, Enikeev, Dmitry, additional, Glybochko, Petr V., additional, Karakiewicz, Pierre I., additional, Nyirady, Peter, additional, Fajkovic, Harun, additional, Haitel, Andrea, additional, Seebacher, Veronika, additional, Rink, Michael, additional, and Shariat, Shahrokh F., additional

Published
2020
Full Text
View/download PDF

50. Expression of urokinase-type plasminogen activator system in non-metastatic prostate cancer

Author

Kimura, Shoji, primary, D’Andrea, David, additional, Iwata, Takehiro, additional, Foerster, Beat, additional, Janisch, Florian, additional, Parizi, Mehdi Kardoust, additional, Moschini, Marco, additional, Briganti, Alberto, additional, Babjuk, Marko, additional, Chlosta, Piotr, additional, Karakiewicz, Pierre I., additional, Enikeev, Dmitry, additional, Rapoport, Leonid M., additional, Seebacher, Veronica, additional, Egawa, Shin, additional, Abufaraj, Mohammad, additional, and Shariat, Shahrokh F., additional

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results